A CCN2 response element exists in the COL1A2 promoter; blocking CCN2 action using an anti-CCN2 antibody or siRNA reduces some effects of bleomycin-induced lung fibrosis [33]. This evidence concerns the gene CCN2 and pulmonary fibrosis.